Risk factors for atrial fibrillation: Not always severe heart disease, not always so "lonely"

Cardiology Journal

Volumn 17, Issue 5, 2010, Pages 437-442

  Rosiak, Marcin ^a   Dziuba, MichaŁ ^a   Chudzik, MichaŁ ^a   Cygankiewicz, Iwona ^a   Bartczak, Karol ^a   Drozdz, JarosŁaw ^a   Wranicz, Jerzy Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Alcohol consumption; Atrial fibrillation; Diabetes; Inflammation; Metabolic syndrome; Obesity; Physical activity; Risk factors; Sleep apnea

Indexed keywords

C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ALCOHOL CONSUMPTION; CARDIOVASCULAR RISK; DIABETES MELLITUS; GENETIC POLYMORPHISM; GLUCOSE INTOLERANCE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; POSITIVE END EXPIRATORY PRESSURE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SLEEP APNEA SYNDROME;

ALCOHOLISM; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; SLEEP APNEA SYNDROMES;

EID: 77957966759     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke, 1991; 22: 983-988.
2. Roy D, Talajic M, Nattel S et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med, 2008; 358: 2667-2677.
3. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation (PIAF). A randomised trial. Lancet, 2000; 356: 1789-1794.
4. Jahangir A, Lee V, Friedman PA et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: A 30-year follow-up study. Circulation, 2007; 115: 3050-3056.
5. Jouven X, Desnos M, Guerot C, Ducimetiere P. Idiopathic atrial fibrillation as a risk factor for mortality. The Paris Prospective Study I. Eur Heart J, 1999; 20: 896-899.
6. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet, 2005; 365: 1415-1428.
7. Rosengren A, Hauptman PJ, Lappas G, Olsson L, Wilhelmsen L, Swedberg K. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J, 2009; 30: 1113-1120.
8. Psaty BM, Manolio TA, Kuller LH et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation, 1997; 96: 2455-2461.
9. Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J Intern Med, 2001; 250: 382-389.
10. Dublin S, French B, Glazer NL et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med, 2006; 166: 2322-2328.
11. Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study. Am J Med, 2005; 118: 489-495.
12. Watanabe H, Tanabe N, Watanabe T et al. Metabolic syndrome and risk of development of atrial fibrillation: The Niigata preventive medicine study. Circulation, 2008; 117: 1255-1260.
13. Schnabel RB, Sullivan LM, Levy D et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): A community-based cohort study. Lancet, 2009; 373: 739-745.
14. Tamakoshi K, Yatsuya H, Kondo T et al. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord, 2003; 27: 443-449.
15. Frohlich M, Imhof A, Berg G et al. Association between C-reactive protein and features of the metabolic syndrome: A population- based study. Diabetes Care, 2000; 23: 1835-1839.
16. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol, 2005; 105: 315-318.
17. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med, 1993; 328: 1230-1235.
18. Roche F, Xuong AN, Court-Fortune et al. Relationship among the severity of sleep apnea syndrome, cardiac arrhythmias, and autonomic imbalance. Pacing Clin Electrophysiol, 2003; 26: 669-677.
19. Niroumand M, Kuperstein R, Sasson Z, Hanly PJ. Impact of obstructive sleep apnea on left ventricular mass and diastolic function. Am J Respir Crit Care Med, 2001; 163: 1632-1636.
20. Gami AS, Pressman G, Caples SM et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation, 2004; 110: 364-367.
21. Kanagala R, Murali NS, Friedman PA et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation, 2003; 107: 2589-2594.
22. Spodick DH. Arrhythmias during acute pericarditis. A prospective study of 100 consecutive cases. JAMA, 1976; 235: 39-41.
23. Bruins P, te Velthius H, Yazdanbakhsh AP et al. Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation, 1997, 96: 3542-3548.
24. Chung MK, Martin DO, Sprecher D et al. C-reactive protein elevation in patients with atrial arrhytmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation, 2001; 104: 2886-2891.
25. Aviles RJ, Martin DO, Apperson-Hansen CA et al. Inflammation as a risk factor for atrial fibrillation. Circulation, 2003; 108: 3006-3010.
26. Loricchio ML, Cianfrocca C, Pasceri V et al. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol, 2007; 99: 1421-1424.
27. Lo B, Fijnheer R, Nierich AP et al. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg, 2005; 79: 1530-1535.
28. Sata N, Hamada N, Horinouchi T et al. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? Jpn Heart J, 2004; 45: 441-445.
29. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation, 1997, 96: 1180-1184.
30. Nakamura Y, Nakamura K, Fukushima-Kusano K et al. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: Possible involvement in intracardiac thrombogenesis. Thromb Res, 2003; 111: 137-142.
31. Healey JS, Baranchuk A, Crystal E et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis. J Am Coll Cardiol, 2005; 45: 1832-1839.
32. Patel AA, White CM, Shah SA, Dale KM, Kluger J, Coleman CI. The relationship between statin use and atrial fibrillation. Curr Med Res Opin, 2007; 23: 1177-1185.
33. Fox CS, Parise H, D'Agostino RB Sr et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA, 2004; 291: 2851-2855.
34. Arnar DO, Thorvaldsson S, Manolio TA et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J, 2006; 27: 708-712.
35. Damani SB, Topol EJ. Molecular genetics of atrial fibrillation. Genome Med, 2009; 1: 54-56.
36. Ettinger PO, Wu CF, De La Cruz C Jr., Weisse AB, Ahmed SS, Regan TJ. Arrhythmias and the 'Holiday Heart': Alcohol-associated cardiac rhythm disorders. Am Heart J, 1978; 95: 555-562.
37. Mukamal KJ, Psaty BM, Rautaharju PM et al. Alcohol consumption and risk and prognosis of atrial fibrillation among older adults: The Cardiovascular Health Study. Am Heart J, 2007; 153: 260-266.
38. Karjalainen J, Kujala UM, Kaprio J, Sarna S, Viitasalo M. Lone atrial fibrillation in vigorously exercising middle aged men: Case--control study. BMJ, 1998; 316: 1784-1785.
39. Mont L, Elosua R, Brugada J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace, 2009; 11: 11-17.
40. Mont L, Tamborero D, Elosua R et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace, 2008; 10: 15-20.